Skip to main content

Triumph Capital Management

Position in PFE — Pfizer Inc

CIK 1730765 DENVER, CO

Position in PFE

as of Jun 30, 2026 · filed Jul 21, 2026
Position Value
$1,449,784
-$134,180 QoQ
Shares Held
60,207
+6.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#1,109
of 2,820 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in PFE Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Triumph Capital Management holds $8,936,522 across 15 Drug Manufacturers - General names. PFE ranks #2 (16.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 PFE
Pfizer Inc
This page
60,207 $1,449,784

All Filings in PFE

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,449,784 60,207
2026-03-31 $1,583,964 56,409
2025-12-31 $457,836 18,387
2025-09-30 $228,708 8,976
2025-06-30 $438,792 18,102
2025-03-31 $218,836 8,636
2024-12-31 $272,807 10,283
2024-09-30 $247,900 8,566
2024-06-30 $1,286,184 45,968
2024-03-31 $771,644 27,807
2023-12-31 $714,567 24,820
2023-09-30 $500,070 15,076
2023-06-30 $518,288 14,130
2023-03-31 $471,566 11,558
2022-12-31 $1,076,449 21,008
2022-09-30 $550,063 12,570
2022-06-30 $280,185 5,344
2022-03-31 $354,158 6,841